Twist Bioscience Corp

Organisation

681 Gateway Boulevard, South San Francisco, CA, United States, 94080

Headquarters

Employees

Health Technology

Industry

Emily Leproust

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. It also provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution. In addition, it offers synthetic SARS-CoV-2 RNA reference sequences as positive controls to develop both NGS and reverse transcription-polymerase chain reaction assays; synthetic monkeypox controls; and various respiratory viral controls, including for influenzas, respiratory syncytial virus, rhinoviruses, SARS, MERS, and coronaviruses. Further, it offers SARS-CoV-2 Research Panels, such as the Twist Respiratory Virus Panel and the Pan-Viral Research Panel, for the detection of disease in a research setting; precision DNA libraries for antibody engineering, affinity maturation, and humanization; and antibody optimization solution to enable simultaneous optimization of multiple characteristics of a given antibody. The company has a strategic collaboration with bitBiome Inc. The company was incorporated in 2013 and is headquartered in South San Francisco, California.

Price

Target

Twist Bioscience Corp (TWST) Price vs Consensus Price Target

As per the chart shown above, analysts believe that the Twist Bioscience Corp (TWST) share price will touch around $49.89 in next 12-months.

Currently 16 wall-street analysts regularly analyze the financials of Twist Bioscience Corp on a frequent basis to provide recommendations along with target share price. 16 analysts offering 12-month price forecasts for Twist Bioscience Corp (TWST) have a share price target of $49.89. This median of share price forecast represents a 15.35% upside from the latest price of $43.25 as on 16.03.26.

Twist Bioscience Corp (TWST) Share Price Forecast

Home

US Stocks

Twist Bioscience Corp (TWST)

Twist Bioscience Corp Stock Forecast

Twist Bioscience Corp Stock Forecast & Price Target (Analyst Recommendation) | INDmoney

Percentage Difference

Twist Bioscience Corp (TWST): Difference between Current Price & Median Forecasted Price

Below is a chart showing the percentage difference between Twist Bioscience Corp's share price and its median forecast price. As on 16.03.26, the difference is -16.77%

Twist Bioscience Corp Forecast and Target Price

Twist Bioscience Corp (TWST) Share Price Forecast

Twist Bioscience Corp (TWST) Price vs Consensus Price Target

Twist Bioscience Corp (TWST) Share Price Forecast v/s Share Price Today

Twist Bioscience Corp (TWST): Difference between Current Price & Median Forecasted Price

Twist Bioscience Corp (TWST) Share Price Technical Analysis

50 Day Moving Average v/s Current Share Price

200 Day Moving Average v/s Current Share Price